Our reviewers are essential in supporting the publication process of Cancer Gene Therapy. Their knowledge and critical evaluation is key and always appreciated. To show our thanks, we present here the profiles those awarded our 'top reviewer' accolade in 2022.

In this collection we highlight a selection of articles from 2022, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo).

Each month or so we will be featuring one of our editorial team, allowing them an opportunity to impart some of their wisdom and knowledge with you, our authors and readers, and you the opportunity to get to know them a little better. Currently featuring Associate Editor, Leandro Castellano

As part of CGT’s continuous effort to provide high quality & innovative research, we have introduced new QC checks: Requirement of a cover letter in an institutional letterhead at first submission; Requirement for institutional e-mail(s) addresses for the corresponding author(s); Inclusion of an Author Contribution statement in the submitted manuscript; Availability of original data upon request